Actively Recruiting

Phase Not Applicable
Age: 6Years - 12Years
All Genders
ID07129967

Oromyofunctional Training: an Innovative Rehabilitation Program for Pediatric Obstructive Sleep Apnea

Led by University Ghent · Updated on 2025-08-19

90

Participants Needed

1

Research Sites

13 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Obstructive sleep apnea (OSA) is a common condition affecting children, impacting their overall health and quality of life. This research aims to evaluate orofacial myofunctional therapy as a new treatment option for pediatric OSA. The study focuses on children aged 6 to 12 years with OSA, especially those who may have limited treatment options beyond standard approaches like surgery. The study involves a 12-week program of orofacial myofunctional therapy, which includes exercises designed to correct abnormal mouth and tongue functions and strengthen muscles that keep the airway open. Participants will receive this therapy to see if it improves their sleep apnea symptoms and related quality of life outcomes. During the study, children will be assessed before and after the 12 weeks of therapy using various tests, including sleep studies, muscle strength measurements, and quality of life questionnaires. Researchers will track changes in apnea-hypopnea index (AHI), orofacial function scores, sleep quality, and patient-reported outcomes to understand the potential benefits and effects of this therapy.

CONDITIONS

Brief Title

Oromyofunctional Training: an Innovative Rehabilitation Program for Pediatric Obstructive Sleep Apnea

Who Can Participate

Age: 6Years - 12Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Children aged between 6 and 12 years
  • Diagnosed with obstructive sleep apnea confirmed by polysomnography (AHI > 1)
Not Eligible

You will not qualify if you...

  • Previous history of orofacial myofunctional therapy
  • Undergoing orthodontic treatment during the study period
  • Receiving treatment for obstructive sleep apnea during the study period
  • Presence of orofacial congenital deformities
  • Mental retardation greater than 2 standard deviations above the 50th percentile

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 12 weeks

Participants undergo 12 weeks of orofacial myofunctional therapy consisting of oropharyngeal exercises to correct abnormal orofacial functions and strengthen upper airway muscles.

Weekly visits for therapy sessions

Trial Site Locations

Total: 1 location

1

Ghent University

Ghent, Belgium, 9000

Actively Recruiting

Loading map...

Research Team

J

Jolien Verbeke, MSc

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

A Modified Baveno Classification of Obstructive Sleep Apnoea...

Obstructive Sleep Apnea (OSA)

Actively Recruiting

18 locations

Assessment of Circuit Rebreathing During Continuous Positive...

Obstructive Sleep Apnea (OSA)

Actively Recruiting

1 location

Impact of Phenotypic and Psychological Characteristics and a...

Obstructive Sleep Apnea (OSA)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here